Randomized Phase 2 Trial of Two Different Doses of Ixazomib in Patients with Relapsed Multiple Myeloma Not Refractory to Bortezomib
Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Shaji K Kumar, Betsy R. Laplant, Craig B. Reeder, Vivek Roy, Francis Buadi, Morie A. Gertz, Kristina Laumann, Peter Leif Bergsagel, Angela Dispenzieri, Prashant Kapoor, Joseph Mikhael, Keith Stewart, Suzanne R. Hayman, Yi L. Hwa, Thomas E. Witzig, Sikander Ailawadhi, David Dingli, Ronald S. Go, Yi Lin, Candido E. Rivera, S. Vincent Rajkumar, Martha Q. Lacy
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2531520114